.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Julphar
Argus Health
US Army
Colorcon
Fuji
Dow
Novartis
Merck
Boehringer Ingelheim

Generated: September 25, 2017

DrugPatentWatch Database Preview

ENDURON Drug Profile

« Back to Dashboard

Which patents cover Enduron, and what generic Enduron alternatives are available?

Enduron is a drug marketed by Abbvie and Abbott and is included in two NDAs.

The generic ingredient in ENDURON is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.

Summary for Tradename: ENDURON

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list38
Patent Applications: see list1,496
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ENDURON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
ENDURON
methyclothiazide
TABLET;ORAL012524-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
ENDURONYL FORTE
deserpidine; methyclothiazide
TABLET;ORAL012775-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ENDURON
methyclothiazide
TABLET;ORAL012524-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
ENDURONYL
deserpidine; methyclothiazide
TABLET;ORAL012775-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
UBS
US Army
QuintilesIMS
Healthtrust
Express Scripts
Fish and Richardson
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot